CBD
Report: FDA chief to resign, leaving CBD review in question
Just as the CBD industry was hoping to start work next month on the cannabinoid’s place in food, drugs and cosmetics, the head of the U.S. Food and Drug Administration chief is resigning. Dr. Scott Gottlieb, who told Congress last week that CBD can’t be added to consumer products,... Read more
Players Network Publishes Updated Investor Presentation and Announces Accompanying Webinar
PNTV will be hosting a live online webinar to present the updated Investor Presentation and further discuss the International business model of Green Leaf Farms International, Inc. at 10:30 am PST (1:30 PM EST) on Thursday, March 7th, 2019. RSVP and RegistrationSpace is limited, please register using the link... Read more
Alabama state officials tell public to avoid CBD products
Retailers who sell CBD products in Alabama are getting mixed messages now that the Department of Health is asking the public to avoid using CBD. It’s a move that directly conflicts with the state’s direction in December that authorized hemp-derived CBD production and sales. While CBD derived from marijuana... Read more
Chart: Farmers and ranchers show interest in growing and using hemp
U.S. farmers and ranchers are interested in growing and using hemp. A recent Farm Journal survey of 950 farmers and ranchers across the United States found that although almost none of them currently grow any form of cannabis, about half would consider doing so – and many would consider... Read more
THC vs. CBD: Which Marijuana Compound Is More Beneficial?
The marijuana compound CBD, or cannabinol, is surging in popularity in the wellness community, for its alleged health benefits, without the high normally associated with pot. But a new study suggests that marijuana’s main active ingredient, THC (tetrahydrocannabinol) — the one that gives users a high — may be more responsible... Read more
Martha Stewart enters the CBD game, will advise Canopy on products
Celebrity lifestyle guru Martha Stewart has agreed to advise Canadian marijuana giant Canopy Growth on hemp-derived CBD products. Stewart said the first collaboration will offer products for pets. Financial terms of the business partnership were not disclosed. The companies did not say if the CBD pet products would be sold in... Read more
States get busy on hemp as USDA delays national hemp rules until 2020
Energized by the 2018 Farm Bill, which removed hemp from the Controlled Substances Act and places federal regulatory authority with the U.S. Department of Agriculture (USDA), states have been readying their hemp cultivation regulatory plans for approval. But those next steps were put on hold on this week when... Read more
Earnings roundup: GW Pharmaceuticals awaiting big CBD drug sales as it reports losses
GW Pharmaceuticals, the drugmaker behind the only federally approved CBD product, is still losing money, though it says it’s happy with early sales of its seizure control drug Epidiolex. Last summer, Epidiolex became the first cannabis-derived treatment approved by the U.S. Food and Drug Administration, prompting the U.S. Drug... Read more
FDA Commissioner gives fresh details on CBD review
In two separate meetings over the past two days, the U.S. Food and Drug Administration offered a glimpse of potential CBD regulations to come and promised an April hearing to start work. FDA Commissioner Dr. Scott Gottlieb told state agriculture regulators that products not approved by the FDA and marketed... Read more
Federal appeals court to review Idaho hemp seizure
A Colorado CBD company seeking the release of hemp seized in Idaho has been granted an appeal from a federal court, but it could be months before the case is resolved. Big Sky Scientific said that nearly 7,000 pounds of industrial hemp seized in Idaho last month was taken unlawfully under... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )